Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

O Sezer

Showing results (91-100 of 112) with videos related to

Pageof 12
Sort By:
European Journal of Cancer (Oxford, England : 1990)|September 22, 2009
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancerR N Whistance, T Conroy, W Chie, et al.
Studies in Health Technology and Informatics|December 8, 1996
Quality monitoring, standardized documentation and management with a computerized system in oncologyT Beinert, M Dubiel, H G Mergenthaler, et al.
Deutsche Medizinische Wochenschrift (1946)|December 18, 2001
[Treatment of fungal infections in hematology and oncology. Guidelines of the Working Party on Infections in Hematology and Oncology (AGIHO) of the German Society for Hematology and Oncology (DGHO)]A Böhme, M Ruhnke, M Karthaus, et al.
Annals of Hematology|September 19, 2003
Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society)H Link, A Böhme, O A Cornely, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma NetworkE Terpos, O Sezer, P I Croucher, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year periodG Maschmeyer, F-L Bertschat, K T Moesta, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2006
Determinants of patient satisfaction in oncology settings from European and Asian countries: preliminary results based on the EORTC IN-PATSAT32 questionnaireA Brédart, C Coens, N Aaronson, et al.
Leukemia|September 3, 2010
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working GroupE Terpos, M A Dimopoulos, O Sezer, et al.
Journal of Hematology & Oncology|January 18, 2018
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert PanelJ Caers, B Paiva, E Zamagni, et al.
British Journal of Haematology|September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study GroupM Hallek, B Schmitt, M Wilhelm, et al.
Pageof 12

Showing results (91-100 of 112) with videos related to

Sort By:
Pageof 12
European Journal of Cancer (Oxford, England : 1990)|September 22, 2009
Clinical and psychometric validation of the EORTC QLQ-CR29 questionnaire module to assess health-related quality of life in patients with colorectal cancerR N Whistance, T Conroy, W Chie, et al.
Studies in Health Technology and Informatics|December 8, 1996
Quality monitoring, standardized documentation and management with a computerized system in oncologyT Beinert, M Dubiel, H G Mergenthaler, et al.
Deutsche Medizinische Wochenschrift (1946)|December 18, 2001
[Treatment of fungal infections in hematology and oncology. Guidelines of the Working Party on Infections in Hematology and Oncology (AGIHO) of the German Society for Hematology and Oncology (DGHO)]A Böhme, M Ruhnke, M Karthaus, et al.
Annals of Hematology|September 19, 2003
Antimicrobial therapy of unexplained fever in neutropenic patients--guidelines of the Infectious Diseases Working Party (AGIHO) of the German Society of Hematology and Oncology (DGHO), Study Group Interventional Therapy of Unexplained Fever, Arbeitsgemeinschaft Supportivmassnahmen in der Onkologie (ASO) of the Deutsche Krebsgesellschaft (DKG-German Cancer Society)H Link, A Böhme, O A Cornely, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|May 26, 2009
The use of bisphosphonates in multiple myeloma: recommendations of an expert panel on behalf of the European Myeloma NetworkE Terpos, O Sezer, P I Croucher, et al.
European Journal of Cancer (Oxford, England : 1990)|March 26, 2003
Outcome analysis of 189 consecutive cancer patients referred to the intensive care unit as emergencies during a 2-year periodG Maschmeyer, F-L Bertschat, K T Moesta, et al.
European Journal of Cancer (Oxford, England : 1990)|December 13, 2006
Determinants of patient satisfaction in oncology settings from European and Asian countries: preliminary results based on the EORTC IN-PATSAT32 questionnaireA Brédart, C Coens, N Aaronson, et al.
Leukemia|September 3, 2010
The use of biochemical markers of bone remodeling in multiple myeloma: a report of the International Myeloma Working GroupE Terpos, M A Dimopoulos, O Sezer, et al.
Journal of Hematology & Oncology|January 18, 2018
Diagnosis, treatment, and response assessment in solitary plasmacytoma: updated recommendations from a European Expert PanelJ Caers, B Paiva, E Zamagni, et al.
British Journal of Haematology|September 1, 2001
Fludarabine plus cyclophosphamide is an efficient treatment for advanced chronic lymphocytic leukaemia (CLL): results of a phase II study of the German CLL Study GroupM Hallek, B Schmitt, M Wilhelm, et al.
Pageof 12